Proteomic screening of variola virus reveals a unique NF-κB inhibitor that is highly conserved among pathogenic orthopoxviruses
Open Access
- 2 June 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (22), 9045-9050
- https://doi.org/10.1073/pnas.0900452106
Abstract
Identification of the binary interactions between viral and host proteins has become a valuable tool for investigating viral tropism and pathogenesis. Here, we present the first systematic protein interaction screening of the unique variola virus proteome by using yeast 2-hybrid screening against a variety of human cDNA libraries. Several protein–protein interactions were identified, including an interaction between variola G1R, an ankryin/F-box containing protein, and human nuclear factor kappa-B1 (NF-κB1)/p105. This represents the first direct interaction between a pathogen-encoded protein and NF-κB1/p105. Orthologs of G1R are present in a variety of pathogenic orthopoxviruses, but not in vaccinia virus, and expression of any one of these viral proteins blocks NF-κB signaling in human cells. Thus, proteomic screening of variola virus has the potential to uncover modulators of the human innate antiviral responses.Keywords
This publication has 51 references indexed in Scilit:
- Ectromelia Virus Encodes a Novel Family of F-Box Proteins That Interact with the SCF ComplexJournal of Virology, 2008
- Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexesProceedings of the National Academy of Sciences, 2008
- Shared Principles in NF-κB SignalingCell, 2008
- Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus disseminationVaccine, 2007
- Polo-like kinase 3 is required for entry into S phaseProceedings of the National Academy of Sciences, 2007
- Poxviral Regulation of the Host NF-κB Response: the Vaccinia Virus M2L Protein Inhibits Induction of NF-κB Activation via an ERK2 Pathway in Virus-Infected Human Embryonic Kidney CellsJournal of Virology, 2006
- Quantification of cAMP antagonist action in vitro and in living cellsEuropean Journal of Cell Biology, 2006
- A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virusProceedings of the National Academy of Sciences, 2006
- The Ubiquitin System for Protein Degradation and Some of Its Roles in the Control of the Cell‐Division Cycle (Nobel Lecture)Angewandte Chemie International Edition, 2005
- A novel genetic system to detect protein–protein interactionsNature, 1989